Ren B, Thelen A P, Peters J M, Gonzalez F J, Jump D B
Departments of Biochemistry and Physiology, Michigan State University, East Lansing, Michigan 48824, USA.
J Biol Chem. 1997 Oct 24;272(43):26827-32. doi: 10.1074/jbc.272.43.26827.
Dietary polyunsaturated fatty acids (PUFA) induce hepatic peroxisomal and microsomal fatty acid oxidation and suppress lipogenic gene expression. The peroxisome proliferator-activated receptor alpha (PPARalpha) has been implicated as a mediator of fatty acid effects on gene transcription. This report uses the PPARalpha-deficient mouse to examine the role of PPARalpha in the PUFA regulation of mRNAs encoding hepatic lipogenic (fatty acid synthase (FAS) and the S14 protein (S14)), microsomal (cytochrome P450 4A2 (CYP4A2)), and peroxisomal (acyl-CoA oxidase (AOX)) enzymes. PUFA ingestion induced mRNAAOX (2.3-fold) and mRNACYP4A2 (8-fold) and suppressed mRNAFAS and mRNAS14 by >/=80% in wild type mice. In PPARalpha-deficient mice, PUFA did not induce mRNAAOX or mRNACYP4A2, indicating a requirement for PPARalpha in the PUFA-mediated induction of these enzymes. However, PUFA still suppressed mRNAFAS and mRNAS14 in the PPARalpha-deficient mice. Studies in rats provided additional support for the differential regulation of lipogenic and peroxisomal enzymes by PUFA. These studies provide evidence for two distinct pathways for PUFA control of hepatic lipid metabolism. One requires PPARalpha and is involved in regulating peroxisomal and microsomal enzymes. The other pathway does not require PPARalpha and is involved in the PUFA-mediated suppression of lipogenic gene expression.
膳食多不饱和脂肪酸(PUFA)可诱导肝脏过氧化物酶体和微粒体脂肪酸氧化,并抑制脂肪生成基因的表达。过氧化物酶体增殖物激活受体α(PPARα)被认为是脂肪酸对基因转录产生影响的介质。本报告利用PPARα基因缺陷小鼠来研究PPARα在PUFA对肝脏脂肪生成(脂肪酸合酶(FAS)和S14蛋白(S14))、微粒体(细胞色素P450 4A2(CYP4A2))及过氧化物酶体(酰基辅酶A氧化酶(AOX))相关酶的mRNA调控中的作用。在野生型小鼠中,摄入PUFA可诱导AOX mRNA(2.3倍)和CYP4A2 mRNA(8倍)表达,并使FAS mRNA和S14 mRNA表达抑制≥80%。在PPARα基因缺陷小鼠中,PUFA未能诱导AOX mRNA或CYP4A2 mRNA表达,这表明PUFA介导的这些酶的诱导过程需要PPARα。然而,PUFA仍可抑制PPARα基因缺陷小鼠中的FAS mRNA和S14 mRNA表达。对大鼠的研究为PUFA对脂肪生成酶和过氧化物酶体酶的差异调控提供了额外支持。这些研究为PUFA控制肝脏脂质代谢的两条不同途径提供了证据。一条途径需要PPARα,并参与调控过氧化物酶体和微粒体酶。另一条途径不需要PPARα,且参与PUFA介导对脂肪生成基因表达的抑制。
Toxicol Appl Pharmacol. 2002-7-1
Antioxidants (Basel). 2024-3-13
Diabetol Metab Syndr. 2022-6-8
J Nutr Biochem. 2018-2-27
Pharmacol Ther. 2017-7-16